Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2025-12-27 @ 2:14 AM
Study NCT ID:
NCT00636168
Status:
COMPLETED
Last Update Posted:
2019-12-17
First Post:
2008-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2013-07-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-07
First Submit QC Date:
None
Study First Post Date:
2008-03-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-07-25
Results First Submit QC Date:
None
Results First Post Date:
2014-08-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-04
Last Update Post Date:
2019-12-17
Last Update Post Date Type:
ACTUAL